2021 CA 15-3/27-29 Testing Market: US, Europe, Japan- Volume and Sales Segment Forecasts-Hospitals, Commercial Labs, POC Locations

July 2021 | - | ID: 293BCDFF57A6EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com provides analysis of CA 15-3/27-29 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

The report is available by section, and can be customized to specific information needs and budget.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

• Hospitals
• Commercial/Private Laboratories
• POC/Decentralized Testing
• Physician Offices/Group Practices
• Cancer Clinics

Contents

TEST ANALYSIS

Clinical significance, current diagnostic procedures, and emerging tests

GEOGRAPHIC COVERAGE

France, Germany, Italy, Japan, Spain, UK, USA

MARKET SEGMENTATION

Centralized Testing
  Hospitals
  Commercial/Private Laboratories
POC/Decentralized Testing

List Of Tables

LIST OF TABLES

France: Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Market Supplier Shares
Germany: Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Market Supplier Shares
Italy: Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Market Supplier Shares
Japan: Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Market Supplier Shares
Spain: Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Market Supplier Shares
UK: Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Market Supplier Shares
USA: Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Market Supplier Shares